The present invention relates to a malaria vaccine which contains: (a) a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3 (b) a polypeptide comprising an amino acid sequence produced by deleting, substituting and/or adding one or several amino acids in the amino acid sequence set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3 and having a preventive effect on malaria or (c) a polypeptide comprising an amino acid sequence having 70% or more sequence identity to the amino acid sequence set forth in SEQ ID NO: 1, SEQ ID NO: 2 or SEQ ID NO: 3 and having a preventive effect on falciparum malaria.